National Institutes of Health Director Jay Bhattacharya testified Thursday morning before the Senate Appropriations Subcommittee regarding President Trump's fiscal 2027 budget request, which includes significant cuts to the agency's funding.

The White House is seeking a $5 billion reduction in NIH funding for the upcoming year, targeting grant and research programs that the administration claims "broke the trust of the American people." The proposed cuts represent a substantial decrease in federal investment in medical research and scientific programs.

Bhattacharya's testimony comes as lawmakers and health leaders are making bipartisan efforts to expand healthcare access and research opportunities. On Wednesday, Representatives Raul Ruiz (D-Calif.) and Erin Houchin (R-Ind.) highlighted their Clinical Trial Modernization Act, which aims to broaden access to clinical trials using tools like artificial intelligence to reach underrepresented communities.

The budget hearing reflects ongoing tensions between fiscal restraint and maintaining federal support for medical research. The NIH traditionally receives bipartisan support in Congress, making the proposed cuts potentially contentious among lawmakers who view medical research funding as essential to public health and scientific advancement.

The testimony is part of the regular appropriations process as Congress reviews the administration's budget proposals for the upcoming fiscal year. Lawmakers will ultimately decide whether to approve, modify, or reject the proposed funding levels for the NIH and its various research programs.